Product Detail
Product NameJAK1 Antibody
Host SpeciesRabbit
ClonalityPolyclonal
PurificationAntibodies were purified by antigen-affinity chromatography.
ApplicationsWB
Species ReactivityHu
SpecificityThe antibody detects endogenous levels of total JAK1 protein.
Immunogen TypeRecombinant Protein
Immunogen DescRecombinant fragment corresponding to a region within amino acids 356 and 686 of JAK1.
Target NameJAK1
ConjugateUnconjugated
Other NamesJAK1A antibody; JAK1B antibody; JTK3 antibody; JAK1 antibody; tyrosine-protein kinase JAK1 antibody; Janus kinase 1 antibody
Accession NoSwiss-Prot#:P23458;
NCBI Gene#:3716
Uniprot
P23458
Gene ID
3716;
Sdspage MW133kd
Concentration1mg/ml
FormulationRabbit IgG in 1XPBS, 1%BSA, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
StorageStore at -20˚C
Application Details
Western blotting: 1:500-1:3000
Sample (30 ug of whole cell lysate)
A: HCT116
5% SDS PAGE
#35530 diluted at 1:500
Janus kinase 1 (JAK1), is a member of a new class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The second phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differs significantly from that of the PTK and threonine/serine kinase family members. JAK1 is a large, widely expressed membrane-associated phosphoprotein. JAK1 is involved in the interferon-alpha/beta and -gamma signal transduction pathways. The reciprocal interdependence between JAK1 and TYK2 activities in the interferon-alpha pathway, and between JAK1 and JAK2 in the interferon-gamma pathway, may reflect a requirement for these kinases in the correct assembly of interferon receptor complexes. These kinases couple cytokine ligand binding to tyrosine phosphorylation of various known signaling proteins and of a unique family of transcription factors termed the signal transducers and activators of transcription, or STATs. [provided by RefSeq]
If you have published an article using product 35530, please notify us so that we can cite your literature.
et al,Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D.In J Exp Clin Cancer Res. On 2018 Nov 27 by Qiang Z, Zhou ZY et al..PMID: 30482227
, (2018),
PMID:
30482227
et al,Dietary quercetin potentiates the antiproliferative effect of interferon-α in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase
, (2017),
PMID:
29371942